Chiesi USA, Inc. recalls
Chiesi USA, Inc. is named on 3 recalls in Recall Relay's records since November 2023, from FDA; the most recent was August 19, 2026.
All 3, newest first.
-
Class IIIofficial
Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) InjectionFailed Stability Specifications: Out of specification stability result for the protein concentration profile.
-
Class IIofficial
Chiesi USA, Inc. recalls CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL)Lack of Assurance of Sterility
-
Class IIofficial
Chiesi USA, Inc. recalls CUROSURF (poractant alfa)Lack of Assurance of Sterility
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Chiesi USA, Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts